
Bal Pharma Ltd is Rated Strong Sell
2026-05-21 10:10:58Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below are based on the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreBoard Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters
05-Aug-2026 | Source : BSEBal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 : Intimation Regarding Notice Of Postal Ballot
30-Jul-2026 | Source : BSECompany Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
Intimation Regarding Corrigendum To The Postal Ballot Notice
23-Jul-2026 | Source : BSEIn Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.
Corporate Actions
12 Aug 2026
Bal Pharma Ltd has declared 12% dividend, ex-date: 18 Sep 25
No Splits history available
No Bonus history available
No Rights history available